Mitochondrial Oxidative Stress and Vascular Health in Chronic Kidney Disease
NCT ID: NCT02364648
Last Updated: 2019-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
24 participants
INTERVENTIONAL
2017-07-01
2019-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Mitochondrial-derived Oxidative Stress to Promote Vascular Endothelial Dysfunction in Non-exercisers With Aging
NCT05872139
Mitochondrial-targeted Antioxidant Supplementation for Improving Age-related Vascular Dysfunction in Humans
NCT04851288
MitoQ Supplementation and Cardiovascular Function in Healthy Men and Women
NCT03586414
MitoQ & Cardiopulmonary Responses During Exercise
NCT06069245
The Efficacy of Oral Mitoquinone (MitoQ) Supplementation for Improving Physiological in Middle-aged and Older Adults
NCT02597023
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MitoQ
4 week 20mg oral daily dose of MitoQ
MitoQ
Mitochondria targeted antioxidant
Placebo
4 week 20mg oral daily placebo
Placebo
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MitoQ
Mitochondria targeted antioxidant
Placebo
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Current pregnancy;
* Uncontrolled hypertension;
* Uncontrolled hyperlipidemia;
* Current hormone replacement therapy;
* Current use of tobacco products;
* Elevated liver enzymes;
* Current autoimmune disease;
* Daily use of of antioxidants \>300mg
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Delaware
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Edwards
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Danielle L Kirkman, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Delaware
David G Edwards, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Delaware
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Kinesiology and Applied Physiology, University of Delaware
Newark, Delaware, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
680076-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.